Author

Naoki Tanimizu

Institute of Medical Science, The University of TokyoORCID 0000-0001-8167-1401Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:scRNA-seq· 1 Approach:statistical model· 1

Frequent Co-Authors

Ayumu OkumuraiD· 1 shared Hideki TaniguchiiD· 1 shared Kenji AoshimaiD· 1 shared Kenta TakeuchiiD· 1 shared Masayuki OhtsukaiD· 1 shared Naoto Yamamoto· 1 shared Ryotaro EtoiD· 1 shared Shunsuke TabeiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Ayumu OkumuraORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Tumor-associated tissue-resident macrophages drive pancreatic cancer progression through IGF1-IGF1R signaling

Yuya Yamamoto, Kenta Takeuchi, Shunsuke Tabe, Ayumu Okumura, Kenji Aoshima, Ryotaro Eto, Takanori Konishi, Naoto Yamamoto, Yohei Miyagi, Masayuki Ohtsuka, Naoki Tanimizu, Hideki Taniguchi

This study identifies TRM-TAMs as drivers of PDAC progression via IGF1-IGF1R signaling and suggests stratifying patients based on TRM-TAM abundance could improve IGF1R-targeted therapy.

bioRxiv · May 12, 2026 · PreprintCancer Biology